Shopping Cart
- Remove All
Your shopping cart is currently empty
Prostaglandin E2 activates four distinct G protein-coupled receptors, EP1-4. Rivenprost is a potent and selective agonist for the EP4 receptor (Ki = 0.7, 56, 620, and >10,000 nM for EP4, EP3, EP2, and EP1, respectively). It has been used to promote EP4-mediated bone formation, prevent bone loss related to osteoporosis, drive osteoblast differentiation, and stabilize bone implants.[1][2][3][4][5] Rivenprost has also been used to support wound healing.[6]

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 100 μg | $142 | 35 days | |
| 500 μg | $539 | 35 days | |
| 1 mg | $987 | 35 days |
| Description | Prostaglandin E2 activates four distinct G protein-coupled receptors, EP1-4. Rivenprost is a potent and selective agonist for the EP4 receptor (Ki = 0.7, 56, 620, and >10,000 nM for EP4, EP3, EP2, and EP1, respectively). It has been used to promote EP4-mediated bone formation, prevent bone loss related to osteoporosis, drive osteoblast differentiation, and stabilize bone implants.[1][2][3][4][5] Rivenprost has also been used to support wound healing.[6] |
| Targets&IC50 | EP4:0.7 nM (Ki) |
| Synonyms | ONO-4819 |
| Molecular Weight | 450.59 |
| Formula | C24H34O6S |
| Cas No. | 256382-08-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMF: 30 mg/mL (66.58 mM), Sonication is recommended. Ethanol: 30 mg/mL (66.58 mM), Sonication is recommended. DMSO: 20 mg/mL (44.39 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/DMF/Ethanol
DMF/Ethanol
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.